Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of ...

Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...

On CNBC's “Halftime Report Final Trades ,” Jim Lebenthal of Cerity Partners said he is long-term bullish but a bit nervous ...

Vertex Pharmaceuticals continues to see patients with sickle ... are no longer cost prohibitive," Marks said earlier this ...

(Reuters) -UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get ...

Cystic fibrosis (CF) patients could be given access to a new drug on the NHS by the end of the year if it is given the green light by the service’s spending watching. The National Institute for Health ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ...

Recent beta upgrade versions of WhatsApp’s Meta AI Android messaging app with integration have been testing two new features: AI-generated group iconography and an AI-powered widget for quicker ...

WhatsApp is expanding its integration of Meta AI with recent beta updates introducing two new features: an AI-powered widget for faster chatbot access and AI-generated group icons. These updates ...

WhatsApp is gearing up to launch a new AI-powered profile picture generator for group chats. According to a report by WABetaInfo, the feature is currently being tested among a limited group of ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...